Context

Part of Janatahack Hackathon in Analytics Vidhya

Content

The healthcare sector has long been an early adopter of and benefited greatly from technological advances. These days, machine learning plays a key role in many health-related realms, including the development of new medical procedures, the handling of patient data, health camps and records, and the treatment of chronic diseases.

MedCamp organizes health camps in several cities with low work life balance. They reach out to working people and ask them to register for these health camps. For those who attend, MedCamp provides them facility to undergo health checks or increase awareness by visiting various stalls (depending on the format of camp).

MedCamp has conducted 65 such events over a period of 4 years and they see a high drop off between “Registration” and number of people taking tests at the Camps. In last 4 years, they have stored data of ~110,000 registrations they have done.

One of the huge costs in arranging these camps is the amount of inventory you need to carry. If you carry more than required inventory, you incur unnecessarily high costs. On the other hand, if you carry less than required inventory for conducting these medical checks, people end up having bad experience.

The Process:

MedCamp employees / volunteers reach out to people and drive registrations.
During the camp, People who “ShowUp” either undergo the medical tests or visit stalls depending on the format of health camp.

Other things to note:

Since this is a completely voluntary activity for the working professionals, MedCamp usually has little profile information about these people.
For a few camps, there was hardware failure, so some information about date and time of registration is lost.
MedCamp runs 3 formats of these camps. The first and second format provides people with an instantaneous health score. The third format provides  
information about several health issues through various awareness stalls.

Favorable outcome:

For the first 2 formats, a favourable outcome is defined as getting a health_score, while in the third format it is defined as visiting at least a stall.
You need to predict the chances (probability) of having a favourable outcome.

Train / Test split:

Camps started on or before 31st March 2006 are considered in Train
Test data is for all camps conducted on or after 1st April 2006.

Acknowledgements

Credits to AV

Inspiration

To share with the data science community to jump start their journey in Healthcare Analytics

The global healthcare industry is huge, and growing everyday. BoldData provides a customized file with all 2.509.454 Healthcare companies of the highest quality. From doctors, physicians to hospitals and nursing homes.

The global healthcare industry is set to grow by 4.82% during 2018, while the pharmaceuticals market saw growth of 5.8% in 2017. We can select your perfect Healthcare companies list on a large number of characteristics: from region to turnover, sector and the number of employees. Discover some of the options in the overview below and request a free quote via the contact form. Are you looking for a different industry region, city or country? No problem: we can help you worldwide with addresses in all industries.

📌**Context**

The Healthcare Workforce Mental Health Dataset is designed to explore workplace mental health challenges in the healthcare industry, an environment known for high stress and burnout rates.

This dataset enables users to analyze key trends related to:

💠 Workplace Stressors: Examining the impact of heavy workloads, poor work environments, and emotional demands.

💠 Mental Health Outcomes: Understanding how stress and burnout influence job satisfaction, absenteeism, and turnover intention.

💠 Educational & Analytical Applications: A valuable resource for data analysts, students, and career changers looking to practice skills in data exploration and data visualization.

To help users gain deeper insights, this dataset is fully compatible with a Power BI Dashboard, available as part of a complete analytics bundle for enhanced visualization and reporting.

📌**Source**

This dataset was synthetically generated using the following methods:

💠 Python & Data Science Techniques: Probabilistic modeling to simulate realistic data distributions. Industry-informed variable relationships based on healthcare workforce studies.

💠 Guidance & Validation Using AI (ChatGPT): Assisted in refining dataset realism and logical mappings.

💠 Industry Research & Reports: Based on insights from WHO, CDC, OSHA, and academic studies on workplace stress and mental health in healthcare settings.

📌**Inspiration**

This dataset was inspired by ongoing discussions in healthcare regarding burnout, mental health, and staff retention. The goal is to bridge the gap between raw data and actionable insights by providing a structured, analyst-friendly dataset.

For those who want a ready-to-use reporting solution, a Power BI Dashboard Template is available, designed for interactive data exploration, workforce insights, and stress factor analysis.

📌**Important Note** This dataset is synthetic and intended for educational purposes only. It is not real-world employee data and should not be used for actual decision-making or policy implementation.

Big Data Analytics in Healthcare Market Outlook

The global market size for Big Data Analytics in Healthcare was valued at approximately USD 34 billion in 2023 and is anticipated to grow at a robust CAGR of 11.9%, reaching an estimated USD 90 billion by 2032. This remarkable growth is driven by the increasing adoption of data-driven decision-making processes within the healthcare sector, spurred by the mounting pressure to enhance operational efficiencies, improve patient outcomes, and reduce overall healthcare costs. The integration of big data analytics within healthcare systems is enabling organizations to leverage vast amounts of data, leading to enhanced patient care and streamlined operations.

A significant growth factor fueling the expansion of the big data analytics market in healthcare is the ever-increasing volume of data generated by healthcare systems. With the surge of electronic health records, wearable health devices, and various other digital health technologies, the volume of data being generated is unprecedented. This data, if analyzed correctly, holds the potential to transform healthcare delivery models, allowing for more precise diagnostics, personalized treatment plans, and proactive disease management strategies. Consequently, healthcare organizations are increasingly investing in big data analytics tools to harness this data for clinical and operational improvements.

Another key driver of market growth is the growing emphasis on value-based care and the need for healthcare providers to demonstrate high-quality patient outcomes. Value-based care models require providers to focus on the quality rather than the quantity of care delivered, inherently demanding the use of advanced analytics to derive actionable insights from patient data. Big data analytics facilitates the identification of patterns and trends that can lead to improved treatment effectiveness and patient satisfaction. This shift in care models is prompting healthcare organizations to integrate sophisticated analytics solutions that help in predictive modeling, trend analysis, and real-time decision-making, further propelling market expansion.

Additionally, the increasing incidence of chronic diseases worldwide is driving the need for more efficient healthcare services. Big data analytics in healthcare can play a critical role in managing chronic diseases by enabling preventive care and personalized treatment plans. By analyzing patient data, including historical health records, genetic information, and lifestyle choices, healthcare providers can predict potential health issues and intervene early, thereby improving patient outcomes and reducing healthcare costs. This capability is essential in managing the global burden of chronic diseases, thereby boosting the adoption of big data analytics solutions in the healthcare sector.

Regionally, North America dominates the market due to the presence of advanced healthcare infrastructure, the availability of technologically advanced products, and the high adoption rate of healthcare IT solutions. The region's robust regulatory environment and substantial investments in healthcare IT make it a fertile ground for the growth of big data analytics solutions. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by increasing government initiatives supporting the digitization of healthcare, burgeoning healthcare infrastructure, and a growing focus on precision medicine. The integration of big data analytics in healthcare across diverse regions is indicative of its global importance in optimizing healthcare delivery and patient care.

Component Analysis

In the realm of big data analytics in healthcare, the component segment is vitally instrumental to the market's evolution and includes software and services. Software solutions are the backbone of big data analytics, providing healthcare organizations with the necessary tools to collect, process, and analyze vast datasets. These solutions encompass data management and analytical platforms, which are indispensable for extracting actionable insights from disparate data sources. The software component is continually evolving with advancements in artificial intelligence and machine learning, which enhance data analytics capabilities. Moreover, the increasing demand for user-friendly, customizable software solutions is driving innovation and growth within this segment.

The services component, on the other hand, plays a critical role in the implementation and maintenance of big data analytics solutions. This component includes cons

Between January and September 2024, healthcare organizations in the United States saw 491 large-scale data breaches, resulting in the loss of over 500 records. This figure has increased significantly in the last decade. To date, the highest number of large-scale data breaches in the U.S. healthcare sector was recorded in 2023, with a reported 745 cases.

The amount of global healthcare data is expected to increase dramatically by the year 2020. Early estimates from 2013 suggest that there were about 153 exabytes of healthcare data generated in that year. However, projections indicate that there could be as much as 2,314 exabytes of new data generated in 2020.

Big Data in Healthcare Market Outlook

According to our latest research, the global Big Data in Healthcare market size reached USD 41.2 billion in 2024, demonstrating robust expansion driven by the increasing adoption of advanced analytics and data-driven decision-making in the healthcare sector. The market is projected to grow at a CAGR of 17.4% from 2025 to 2033, reaching an estimated value of USD 154.1 billion by 2033. This significant growth is primarily attributed to the surging volume of healthcare data, advancements in artificial intelligence and machine learning, and the increasing focus on improving patient outcomes and operational efficiency across healthcare institutions worldwide.

One of the primary growth factors fueling the Big Data in Healthcare market is the exponential rise in healthcare data generation, driven by the widespread adoption of electronic health records (EHRs), wearable devices, and connected medical equipment. As healthcare organizations seek to harness actionable insights from this data deluge, the demand for advanced analytics solutions has surged. The integration of big data analytics enables providers to enhance clinical decision-making, reduce medical errors, and optimize treatment protocols, thereby improving patient care and safety. Furthermore, the growing emphasis on value-based care models has compelled healthcare stakeholders to invest in robust data analytics platforms that can support population health management and evidence-based medicine, further accelerating market expansion.

Another key driver of the Big Data in Healthcare market is the growing need for cost containment and operational efficiency within healthcare organizations. Rising healthcare costs, resource constraints, and the increasing complexity of healthcare delivery have prompted providers and payers to leverage big data analytics to streamline operations, reduce redundancies, and enhance resource allocation. Financial analytics applications, in particular, are witnessing substantial uptake as organizations strive to identify cost-saving opportunities, detect fraudulent claims, and improve revenue cycle management. Additionally, operational analytics solutions are being deployed to optimize supply chain management, workforce planning, and facility utilization, resulting in enhanced productivity and reduced overheads.

The rapid advancement of artificial intelligence (AI), machine learning, and cloud computing technologies has also played a pivotal role in propelling the Big Data in Healthcare market forward. AI-driven analytics platforms are enabling healthcare providers to uncover hidden patterns in patient data, predict disease outbreaks, and personalize treatment plans based on individual patient profiles. The proliferation of cloud-based solutions has further democratized access to advanced analytics tools, allowing even small and medium-sized healthcare organizations to leverage big data capabilities without significant upfront investments in IT infrastructure. This technological evolution is expected to continue driving innovation and adoption across the global healthcare landscape.

From a regional perspective, North America continues to dominate the Big Data in Healthcare market, accounting for the largest revenue share in 2024, followed by Europe and Asia Pacific. The region's leadership is underpinned by robust healthcare IT infrastructure, high adoption rates of electronic health records, and strong government initiatives promoting data interoperability and healthcare digitization. Meanwhile, Asia Pacific is poised for the fastest growth during the forecast period, fueled by rapid healthcare modernization, expanding digital health initiatives, and increasing investments in healthcare analytics by both public and private sectors. As healthcare systems worldwide continue to prioritize data-driven transformation, the market's regional landscape is expected to evolve, with emerging economies playing an increasingly prominent role in shaping future growth trajectories.

Update — December 7, 2014. – Evidence-based medicine (EBM) is not working for many reasons, for example: 1. Incorrect in their foundations (paradox): hierarchical levels of evidence are supported by opinions (i.e., lowest strength of evidence according to EBM) instead of real data collected from different types of study designs (i.e., evidence). http://dx.doi.org/10.6084/m9.figshare.1122534 2. The effect of criminal practices by pharmaceutical companies is only possible because of the complicity of others: healthcare systems, professional associations, governmental and academic institutions. Pharmaceutical companies also corrupt at the personal level, politicians and political parties are on their payroll, medical professionals seduced by different types of gifts in exchange of prescriptions (i.e., bribery) which very likely results in patients not receiving the proper treatment for their disease, many times there is no such thing: healthy persons not needing pharmacological treatments of any kind are constantly misdiagnosed and treated with unnecessary drugs. Some medical professionals are converted in K.O.L. which is only a puppet appearing on stage to spread lies to their peers, a person supposedly trained to improve the well-being of others, now deceits on behalf of pharmaceutical companies. Probably the saddest thing is that many honest doctors are being misled by these lies created by the rules of pharmaceutical marketing instead of scientific, medical, and ethical principles. Interpretation of EBM in this context was not anticipated by their creators. “The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs.” ―Peter C. Gøtzsche “doctors and their organisations should recognise that it is unethical to receive money that has been earned in part through crimes that have harmed those people whose interests doctors are expected to take care of. Many crimes would be impossible to carry out if doctors weren’t willing to participate in them.” —Peter C Gøtzsche, The BMJ, 2012, Big pharma often commits corporate crime, and this must be stopped. Pending (Colombia): Health Promoter Entities (In Spanish: EPS ―Empresas Promotoras de Salud).

1. Misinterpretations New technologies or concepts are difficult to understand in the beginning, it doesn’t matter their simplicity, we need to get used to new tools aimed to improve our professional practice. Probably the best explanation is here in these videos (credits to Antonio Villafaina for sharing these videos with me). English https://www.youtube.com/watch?v=pQHX-SjgQvQ&w=420&h=315 Spanish https://www.youtube.com/watch?v=DApozQBrlhU&w=420&h=315 ----------------------- Hypothesis: hierarchical levels of evidence based medicine are wrong Dear Editor, I have data to support the hypothesis described in the title of this letter. Before rejecting the null hypothesis I would like to ask the following open question:Could you support with data that hierarchical levels of evidence based medicine are correct? (1,2) Additional explanation to this question: – Only respond to this question attaching publicly available raw data.– Be aware that more than a question this is a challenge: I have data (i.e., evidence) which is contrary to classic (i.e., McMaster) or current (i.e., Oxford) hierarchical levels of evidence based medicine. An important part of this data (but not all) is publicly available. References
2. Ramirez, Jorge H (2014): The EBM challenge. figshare. http://dx.doi.org/10.6084/m9.figshare.1135873
3. The EBM Challenge Day 1: No Answers. Competing interests: I endorse the principles of open data in human biomedical research Read this letter on The BMJ – August 13, 2014.http://www.bmj.com/content/348/bmj.g3725/rr/762595Re: Greenhalgh T, et al. Evidence based medicine: a movement in crisis? BMJ 2014; 348: g3725. _ Fileset contents Raw data: Excel archive: Raw data, interactive figures, and PubMed search terms. Google Spreadsheet is also available (URL below the article description). Figure 1. Unadjusted (Fig 1A) and adjusted (Fig 1B) PubMed publication trends (01/01/1992 to 30/06/2014). Figure 2. Adjusted PubMed publication trends (07/01/2008 to 29/06/2014) Figure 3. Google search trends: Jan 2004 to Jun 2014 / 1-week periods. Figure 4. PubMed publication trends (1962-2013) systematic reviews and meta-analysis, clinical trials, and observational studies.
   Figure 5. Ramirez, Jorge H (2014): Infographics: Unpublished US phase 3 clinical trials (2002-2014) completed before Jan 2011 = 50.8%. figshare.http://dx.doi.org/10.6084/m9.figshare.1121675 Raw data: "13377 studies found for: Completed | Interventional Studies | Phase 3 | received from 01/01/2002 to 01/01/2014 | Worldwide". This database complies with the terms and conditions of ClinicalTrials.gov: http://clinicaltrials.gov/ct2/about-site/terms-conditions Supplementary Figures (S1-S6). PubMed publication delay in the indexation processes does not explain the descending trends in the scientific output of evidence-based medicine. Acknowledgments I would like to acknowledge the following persons for providing valuable concepts in data visualization and infographics:
4. Maria Fernanda Ramírez. Professor of graphic design. Universidad del Valle. Cali, Colombia.
5. Lorena Franco. Graphic design student. Universidad del Valle. Cali, Colombia. Related articles by this author (Jorge H. Ramírez)
6. Ramirez JH. Lack of transparency in clinical trials: a call for action. Colomb Med (Cali) 2013;44(4):243-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/24892242
7. Ramirez JH. Re: Evidence based medicine is broken (17 June 2014). http://www.bmj.com/node/759181
8. Ramirez JH. Re: Global rules for global health: why we need an independent, impartial WHO (19 June 2014). http://www.bmj.com/node/759151
9. Ramirez JH. PubMed publication trends (1992 to 2014): evidence based medicine and clinical practice guidelines (04 July 2014). http://www.bmj.com/content/348/bmj.g3725/rr/759895 Recommended articles
10. Greenhalgh Trisha, Howick Jeremy,Maskrey Neal. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725
11. Spence Des. Evidence based medicine is broken BMJ 2014; 348:g22
12. Schünemann Holger J, Oxman Andrew D,Brozek Jan, Glasziou Paul, JaeschkeRoman, Vist Gunn E et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 2008; 336:1106
13. Lau Joseph, Ioannidis John P A, TerrinNorma, Schmid Christopher H, OlkinIngram. The case of the misleading funnel plot BMJ 2006; 333:597
14. Moynihan R, Henry D, Moons KGM (2014) Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med 11(7): e1001655. doi:10.1371/journal.pmed.1001655
15. Katz D. A-holistic view of evidence based medicinehttp://thehealthcareblog.com/blog/2014/05/02/a-holistic-view-of-evidence-based-medicine/ ---

In 2023, there were more than *** incidents of data compromises in the healthcare sector in the United States. Reaching its all-time highest. This indicates a significant growth since 2005 when the industry saw only ** cases of data compromises in the country.

The big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% till 2035

Salutary Data is a boutique, B2B contact and company data provider that's committed to delivering high quality data for sales intelligence, lead generation, marketing, recruiting / HR, identity resolution, and ML / AI. Our database currently consists of 148MM+ highly curated B2B Contacts ( US only), along with over 4M+ companies, and is updated regularly to ensure we have the most up-to-date information.

We can enrich your in-house data ( CRM Enrichment, Lead Enrichment, etc.) and provide you with a custom dataset ( such as a lead list) tailored to your target audience specifications and data use-case. We also support large-scale data licensing to software providers and agencies that intend to redistribute our data to their customers and end-users.

What makes Salutary unique? - We offer our clients a truly unique, one-stop aggregation of the best-of-breed quality data sources. Our supplier network consists of numerous, established high quality suppliers that are rigorously vetted. - We leverage third party verification vendors to ensure phone numbers and emails are accurate and connect to the right person. Additionally, we deploy automated and manual verification techniques to ensure we have the latest job information for contacts. - We're reasonably priced and easy to work with.

Products: API Suite Web UI Full and Custom Data Feeds

Services: Data Enrichment - We assess the fill rate gaps and profile your customer file for the purpose of appending fields, updating information, and/or rendering net new “look alike” prospects for your campaigns. ABM Match & Append - Send us your domain or other company related files, and we’ll match your Account Based Marketing targets and provide you with B2B contacts to campaign. Optionally throw in your suppression file to avoid any redundant records. Verification (“Cleaning/Hygiene”) Services - Address the 2% per month aging issue on contact records! We will identify duplicate records, contacts no longer at the company, rid your email hard bounces, and update/replace titles or phones. This is right up our alley and levers our existing internal and external processes and systems.

The Nuclear Medicine National HQ System database is a series of MS Excel spreadsheets and Access Database Tables by fiscal year. They consist of information from all Veterans Affairs Medical Centers (VAMCs) performing or contracting nuclear medicine services in Veterans Affairs medical facilities. The medical centers are required to complete questionnaires annually (RCS 10-0010-Nuclear Medicine Service Annual Report). The information is then manually entered into the Access Tables, which includes: * Distribution and cost of in-house VA - Contract Physician Services, whether contracted services are made via sharing agreement (with another VA medical facility or other government medical providers) or with private providers. * Workload data for the performance and/or purchase of PET/CT studies. * Organizational structure of services. * Updated changes in key imaging service personnel (chiefs, chief technicians, radiation safety officers). * Workload data on the number and type of studies (scans) performed, including Medicare Relative Value Units (RVUs), also referred to as Weighted Work Units (WWUs). WWUs are a workload measure calculated as the product of a study's Current Procedural Terminology (CPT) code, which consists of total work costs (the cost of physician medical expertise and time), and total practice costs (the costs of running a practice, such as equipment, supplies, salaries, utilities etc). Medicare combines WWUs together with one other parameter to derive RVUs, a workload measure widely used in the health care industry. WWUs allow Nuclear Medicine to account for the complexity of each study in assessing workload, that some studies are more time consuming and require higher levels of expertise. This gives a more accurate picture of workload; productivity etc than using just 'total studies' would yield. * A detailed Full-Time Equivalent Employee (FTEE) grid, and staffing distributions of FTEEs across nuclear medicine services. * Information on Radiation Safety Committees and Radiation Safety Officers (RSOs). Beginning in 2011 this will include data collection on part-time and non VA (contract) RSOs; other affiliations they may have and if so to whom they report (supervision) at their VA medical center.Collection of data on nuclear medicine services' progress in meeting the special needs of our female veterans. Revolving documentation of all major VA-owned gamma cameras (by type) and computer systems, their specifications and ages. * Revolving data collection for PET/CT cameras owned or leased by VA; and the numbers and types of PET/CT studies performed on VA patients whether produced on-site, via mobile PET/CT contract or from non-VA providers in the community.* Types of educational training/certification programs available at VA sites * Ongoing funded research projects by Nuclear Medicine (NM) staff, identified by source of funding and research purpose. * Data on physician-specific quality indicators at each nuclear medicine service.* Academic achievements by NM staff, including published books/chapters, journals and abstracts. * Information from polling field sites re: relevant issues and programs Headquarters needs to address. * Results of a Congressionally mandated contracted quality assessment exercise, also known as a Proficiency study. Study results are analyzed for comparison within VA facilities (for example by mission or size), and against participating private sector health care groups. * Information collected on current issues in nuclear medicine as they arise. Radiation Safety Committee structures and membership, Radiation Safety Officer information and information on how nuclear medicine services provided for female Veterans are examples of current issues.The database is now stored completely within MS Access Database Tables with output still presented in the form of Excel graphs and tables.

In 2023, the most significant healthcare data breach incident in the United States was the HCA Healthcare breach. The Nashville-based company is the largest health system in the United States. During the July 2023 breach, more than *** U.S. hospitals and ***** healthcare sites reported about unauthorized access. The incident impacted ***** million individuals in the United States. Second-ranked PJ&A data breach impacted nearly **** million individuals.

Healthcare Cloud Based Analytics Market Outlook

The global healthcare cloud based analytics market size was valued at approximately USD 14.8 billion in 2023, and it is anticipated to reach around USD 54.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2032. One of the primary growth factors influencing this market is the increasing demand for data-driven decision-making processes in healthcare settings to enhance patient outcomes and operational efficiency.

One significant growth factor for the healthcare cloud based analytics market is the rapid digital transformation within the healthcare sector. The transition from paper-based systems to electronic health records (EHRs) and the adoption of telehealth services are driving the need for sophisticated analytics solutions that can process vast amounts of healthcare data. The accessibility and scalability offered by cloud-based solutions make them particularly attractive for healthcare providers looking to leverage patient data for better diagnostic and treatment outcomes.

Moreover, the rising focus on personalized medicine and the need for population health management are propelling the demand for healthcare cloud based analytics. Personalized medicine requires the analysis of large datasets to understand individual patient profiles and predict responses to treatments. Similarly, population health management aims to improve health outcomes by analyzing data to identify trends and intervene proactively. Cloud-based analytics platforms provide the necessary computational power and flexibility to handle these complex data requirements efficiently.

The cost-efficiency of cloud based solutions compared to traditional on-premises systems is another crucial growth driver. Healthcare organizations are under constant pressure to reduce operational costs while improving patient care quality. Cloud-based analytics solutions eliminate the need for significant upfront investments in hardware and software while offering the benefits of scalable resources and reduced IT maintenance costs. This financial advantage is particularly appealing to small and medium-sized healthcare providers who may have limited budgets for technology investments.

The integration of Business Intelligence in Healthcare is transforming the way data is utilized to improve patient care and streamline operations. By employing BI tools, healthcare organizations can analyze vast datasets to uncover insights that drive better decision-making. These tools enable healthcare providers to track patient outcomes, optimize resource allocation, and enhance overall operational efficiency. The ability to visualize data through dashboards and reports allows for a deeper understanding of patient trends and organizational performance, ultimately leading to improved healthcare delivery and patient satisfaction.

From a regional perspective, North America currently holds the largest market share in the healthcare cloud based analytics market, driven by advanced healthcare infrastructure and high adoption rates of digital healthcare technologies. However, regions like Asia Pacific are expected to witness the highest growth rates during the forecast period. Factors such as increasing healthcare expenditures, growing awareness about the benefits of healthcare analytics, and supportive government initiatives are contributing to the market expansion in these regions.

Component Analysis

The healthcare cloud based analytics market can be segmented by component into software and services. The software segment includes various analytics platforms and tools designed to process and analyze healthcare data. These software solutions are essential for enabling healthcare providers to harness the power of big data and derive actionable insights. As the volume of healthcare data continues to grow exponentially, the demand for robust and scalable analytics software solutions is expected to increase significantly. Innovations in artificial intelligence and machine learning are also enhancing the capabilities of these software solutions, making them more effective in predictive analytics and decision support.

Cloud Computing in Healthcare is revolutionizing the way healthcare data is stored, accessed, and analyzed. By leveraging cloud technology, healthcar

The North American clinical data analytics market in healthcare is experiencing robust growth, projected to reach $12.85 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 14.43% from 2025 to 2033. This expansion is driven by several key factors. The increasing volume of patient data generated through electronic health records (EHRs) and wearable devices necessitates advanced analytics for improved clinical decision-making. Furthermore, a growing emphasis on value-based care and the need for better population health management are pushing healthcare providers and payers to adopt data analytics solutions. The rising adoption of cloud-based solutions offers scalability and cost-effectiveness, accelerating market growth. Descriptive, diagnostic, predictive, and prescriptive analytics are all gaining traction, with predictive and prescriptive analytics showing particularly strong growth as organizations aim to anticipate patient needs and optimize resource allocation. The major players like IBM, Philips, and Cerner are driving innovation and market penetration through strategic partnerships and technological advancements. The market segmentation reveals a strong preference for cloud-based delivery models due to their flexibility and accessibility. Diagnostic and predictive analytics segments are experiencing faster growth compared to descriptive analysis, reflecting the industry's increasing focus on proactive care and risk mitigation. Payers are significant adopters of clinical data analytics, leveraging the technology for fraud detection, risk assessment, and network optimization. However, concerns regarding data security, interoperability challenges, and the need for skilled professionals to interpret and utilize the complex analytics outputs represent notable restraints. Future growth will likely be fueled by further technological advancements such as artificial intelligence (AI) and machine learning (ML) integration, enhanced data security measures, and increasing government support for digital health initiatives. The North American market, particularly the United States, is expected to remain the dominant region due to its advanced healthcare infrastructure and higher adoption rates. This comprehensive report provides an in-depth analysis of the North America clinical data analytics in healthcare industry, covering the period from 2019 to 2033. It offers valuable insights into market size, growth drivers, challenges, and key players, utilizing data from the base year 2025 and estimating the market value up to 2033. The report meticulously examines market segmentation by mode of delivery (cloud, on-premise), analytics type (descriptive, diagnostic, predictive, prescriptive), and end-user (payers, providers). This report is essential for stakeholders seeking to understand and navigate this rapidly evolving market landscape. Recent developments include: June 2023: MRO Corp., a clinical data exchange The company said it has started a new technology solution. The company implemented a digital and automated process of requesting and delivering patient information between providers and payers by means of this solution. MRO aims at removing the manual burden and reducing friction between providers. Payer Exchange automates the labor-intensive work previously performed by hospital staff to streamline workflows., April 2023: TripleBlind, a US-based healthcare analytics company, announced the launch of three new healthcare-focused products. The new product offered by the company provides secure accessibility to sensitive data, allowing healthcare users to gain detailed insights while maintaining privacy and compliance.. Key drivers for this market are: Increasing Healthcare Spending, Increasing Adoption of Big Data in Healthcare. Potential restraints include: High Cost of Data Analytics Solutions. Notable trends are: Cloud to Witness Significant Growth.

The average number of hospital beds available per 1,000 people in the United States was forecast to continuously decrease between 2024 and 2029 by in total 0.1 beds (-3.7 percent). After the eighth consecutive decreasing year, the number of available beds per 1,000 people is estimated to reach 2.63 beds and therefore a new minimum in 2029. Depicted is the number of hospital beds per capita in the country or region at hand. As defined by World Bank this includes inpatient beds in general, specialized, public and private hospitals as well as rehabilitation centers.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to 150 countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the average number of hospital beds available per 1,000 people in countries like Canada and Mexico.

Dataset, GDB, and Online Map created by Renee Haley, NMCDC, May 2023 DATA ACQUISITION PROCESS

Scope and purpose of project: New Mexico is struggling to maintain its healthcare workforce, particularly in Rural areas. This project was undertaken with the intent of looking at flows of healthcare workers into and out of New Mexico at the most granular geographic level possible. This dataset, in combination with others (such as housing cost and availability data) may help us understand where our healthcare workforce is relocating and why.

The most relevant and detailed data on workforce indicators in the United States is housed by the Census Bureau's Longitudinal Employer-Household Dynamics, LEHD, System. Information on this system is available here:

https://lehd.ces.census.gov/

The Job-to-Job flows explorer within this system was used to download the data. Information on the J2J explorer can ve found here:

https://j2jexplorer.ces.census.gov/explore.html#1432012

The dataset was built from data queried with the LED Extraction Tool, which allows for the query of more intersectional and detailed data than the explorer. This is a link to the LED extraction tool:

https://ledextract.ces.census.gov/

The geographies used are US Metro areas as determined by the Census, (N=389). The shapefile is named lehd_shp_gb.zip, and can be downloaded under this section of the following webpage: 5.5. Job-to-Job Flow Geographies, 5.5.1. Metropolitan (Complete). A link to the download site is available below:

https://lehd.ces.census.gov/data/schema/j2j_latest/lehd_shapefiles.html

DATA CLEANING PROCESS

This dataset was built from 8 non intersectional datasets downloaded from the LED Extraction Tool.

Separate datasets were downloaded in order to obtain detailed information on the race, ethnicity, and educational attainment levels of healthcare workers and where they are migrating.

Datasets included information for the four separate quarters of 2021. It was not possible to download annual data, only quarterly. Quarterly data was summed in a later step to derive annual totals for 2021.

4 datasets for healthcare workers moving OUT OF New Mexico, with details on race, ethnicity, and educational attainment, were downloaded. 1 contained information on educational attainment, 2 contained information on 7 racial categories identifying as non- Hispanic, 3 contained information on those same 7 categories also identifying as Hispanic, and 4 contained information for workers identifying as white and Hispanic.

4 datasets for healthcare worker moving INTO New Mexico, with details on race, ethnicity, and educational attainment, were downloaded with the same details outlined above.

Each dataset was cleaned according to Data Template which kept key attributes and discarded excess information. Within each dataset, the J2J Indicators reflecting 6 different types of job migration were totaled in order to simplify analysis, as this information was not needed in detail.

After cleaning, each set of 4 datasets for workers moving INTO New Mexico were joined. The process was repeated for workers moving OUT OF New Mexico. This resulted 2 main datasets.

These 2 main datasets still listed all of the variables by each quarter of 2021. Because of this the data was split in JMP, so that attributes of educational attainment, race and ethnicity, of workers migrating by quarter were moved from rows to columns. After this, summary columns for the year of 2021 were derived. This resulted in totals columns for workers identifying as: 6 separate races and all ethnicities, all races and Hispanic, white-Hispanic, and workers of 6 different education levels, reflecting how many workers of each indicator migrated to and from metro areas in New Mexico in 2021.

The data split transposed duplicate rows reflecting differing worker attributes within the same metro area, resulting in one row for each metro area and reflecting the attributes in columns, thus resulting in a mappable dataset.

The 2 datasets were joined (on Metro Area) resulting in one master file containing information on healthcare workers entering and leaving New Mexico.

Rows (N=389) reflect all of the metro areas across the US, and each state. Rows include the 5 metro areas within New Mexico, and New Mexico State.

Columns (N=99) contain information on worker race, ethnicity and educational attainment, specific to each metro area in New Mexico.

78 of these rows reflect workers of specific attributes moving OUT OF the 5 specific Metro Areas in New Mexico and totals for NM State. This level of detail is intended for analyzing who is leaving what area of New Mexico, where they are going to, and why.

13 Columns reflect each worker attribute for healthcare workers moving INTO New Mexico by race, ethnicity and education level. Because all 5 metro areas and New Mexico state are contained in the rows, this information for incoming workers is available by metro area and at the state level - there is less possability for mapping these attributes since it was not realistic or possible to create a dataset reflecting all of these variables for every healthcare worker from every metro area in the US also coming into New Mexico (that dataset would have over 1,000 columns and be unmappable). Therefore this dataset is easier to utilize in looking at why workers are leaving the state but also includes detailed information on who is coming in.

The remaining 8 columns contain geographic information.

GIS AND MAPPING PROCESS

The master file was opened in Arc GIS Pro and the Shapefile of US Metro Areas was also imported

The excel file was joined to the shapefile by Metro Area Name as they matched exactly

The resulting layer was exported as a GDB in order to retain null values which would turn to zeros if exported as a shapefile.

This GDB was uploaded to Arc GIS Online, Aliases were inserted as column header names, and the layer was visualized as desired.

SYSTEMS USED

MS Excel was used for data cleaning, summing NM state totals, and summing quarterly to annual data.

JMP was used to transpose, join, and split data.

ARC GIS Desktop was used to create the shapefile uploaded to NMCDC's online platform.

VARIABLE AND RECODING NOTES

Summary of variables selected for datasets downloaded focused on educational attainment:

J2J Flows by Educational Attainment

Summary of variables selected for datasets downloaded focused on race and ethnicity:

J2J Flows by Race and Ethnicity

Note: Variables in Datasets 1 through 4 downloaded twice, once for workers coming into New Mexico and once for those leaving NM. VARIABLE: LEHD VARIABLE DEFINITION LEHD VARIABLE NOTES DETAILS OR URL FOR RAW DATA DOWNLOAD

Geography Type - State Origin and Destination State

Data downloaded for worker migration into and out of all US States

Geography Type - Metropolitan Areas Origin and Dest Metro Area

Data downloaded for worker migration into and out of all US Metro Areas

NAICS sectors North American Industry Classification System Under Firm Characteristics Only downloaded for Healthcare and Social Assistance Sectors

Other Firm Characteristics No Firm Age / Size Detail Under Firm Characteristics Downloaded data on all firm ages, sizes, and other details.

Worker Characteristics Education, Race, Ethnicity

Non Intersectional data aside from Race / Ethnicity data.

Sex Gender

0 - All Sexes Selected

Age Age

A00 All Ages (14-99)

Education Education Level E0, E1, E2, E3, 34, E5 E0 - All Education Categories, E1 - Less than high school, E2 - High school or equivalent, no college, E3 - Some college or Associate’s degree, E4 - Bachelor's degree or advanced degree, E5 - Educational attainment not available (workers aged 24 or younger)

Dataset 1 All Education Levels, E1, E2, E3, E4, and E5

RACE

A0, A1, A2, A3, A4, A5 OPTIONS: A0 All Races, A1 White Alone, A2 Black or African American Alone, A3 American Indian or Alaska Native Alone, A4 Asian Alone, A5 Native Hawaiian or Other Pacific Islander Alone, SDA7 Two or More Race Groups

ETHNICITY

A0, A1, A2 OPTIONS: A0 All Ethnicities, A1 Not Hispanic or Latino, A2 Hispanic or Latino

Dataset 2 All Races (A0) and All Ethnicities (A0)

Dataset 3 6 Races (A1 through A5) and All Ethnicities (A0)

Dataset 4 White (A1) and Hispanic or Latino (A1)

Quarter Quarter and Year

Data from all quarters of 2021 to sum into annual numbers; yearly data was not available

Employer type Sector: Private or Governmental

Query included all healthcare sector workflows from all employer types and firm sizes from every quarter of 2021

J2J indicator categories Detailed types of job migration

All options were selected for all datasets and totaled: AQHire, AQHireS, EE, EES, J2J, J2JS. Counts were selected vs. earnings, and data was not seasonally adjusted (unavailable).

NOTES AND RESOURCES

The following resources and documentation were used to navigate the LEHD and J2J Worker Flows system and to answer questions about variables:

https://lehd.ces.census.gov/data/schema/j2j_latest/lehd_public_use_schema.html

https://www.census.gov/history/www/programs/geography/metropolitan_areas.html

https://lehd.ces.census.gov/data/schema/j2j_latest/lehd_csv_naming.html

Statewide (New

Success.ai’s Healthcare Marketing Data provides businesses with a robust dataset of verified contact details, operational insights, and decision-maker profiles for healthcare companies worldwide. Covering hospitals, pharmaceutical firms, biotechnology companies, medical equipment manufacturers, and healthcare service providers, this dataset offers unparalleled visibility into the global healthcare industry.

With access to over 170 million verified professional profiles and 30 million company profiles, Success.ai ensures that your outreach, research, and business development initiatives are informed by reliable, continuously updated, and AI-validated data. Backed by our Best Price Guarantee, this solution empowers you to connect with key stakeholders driving healthcare innovation and delivery.

Why Choose Success.ai’s Healthcare Contact Data?

1. Verified Contact Data for Precision Outreach

   • Access verified work emails, direct phone numbers, and LinkedIn profiles of healthcare executives, procurement managers, compliance officers, and operational leads.
   • AI-driven validation ensures 99% accuracy, reducing bounce rates and enabling confident communication.

2. Global Coverage Across Healthcare Sectors

   • Includes profiles of hospitals, clinics, pharmaceutical companies, biotech firms, and medical device manufacturers spanning all major markets.
   • Gain visibility into healthcare systems across North America, Europe, Asia-Pacific, South America, and the Middle East.

3. Continuously Updated Datasets

   • Real-time updates reflect leadership changes, company expansions, new product launches, and regulatory compliance updates.
   • Stay aligned with the dynamic healthcare landscape to seize opportunities and build meaningful partnerships.

4. Ethical and Compliant

   • Adheres to GDPR, CCPA, and other global privacy regulations, ensuring responsible use of data and compliance with industry standards.

Data Highlights:

• 170M+ Verified Professional Profiles: Engage with decision-makers, medical directors, R&D heads, and compliance officers across the global healthcare industry.
• 30M Company Profiles: Access comprehensive firmographic data, including operational scopes, revenue ranges, and geographic distributions.
• Leadership Contact Details: Connect with CEOs, CMOs, CTOs, and department heads shaping healthcare innovation and strategy.
• Operational Insights: Gain visibility into supply chains, product pipelines, and regulatory certifications.

Key Features of the Dataset:

1. Decision-Maker Profiles in Healthcare

   • Identify and engage with executives, clinical directors, procurement leads, and R&D professionals responsible for strategic decisions.
   • Target professionals influencing drug development, technology adoption, and patient care delivery.

2. Advanced Filters for Precision Targeting

   • Filter companies by industry segment (hospitals, biotech, pharma, medical devices), geographic location, company size, or operational focus.
   • Tailor campaigns to address specific needs such as regulatory compliance, cost efficiency, or technological modernization.

3. AI-Driven Enrichment

   • Profiles enriched with actionable data allow you to craft personalized messaging, highlight value propositions, and improve engagement with healthcare stakeholders.

Strategic Use Cases:

1. Sales and Lead Generation

   • Offer healthcare technology solutions, medical devices, or consulting services to hospitals, pharmaceutical firms, or biotech startups.
   • Build relationships with procurement managers and clinical leads responsible for vendor selection and resource allocation.

2. Market Research and Competitive Analysis

   • Analyze trends in patient care, drug pipelines, and healthcare delivery models to guide product development and marketing strategies.
   • Benchmark against competitors to identify market gaps, emerging trends, and untapped opportunities.

3. Regulatory Compliance and Risk Mitigation

   • Connect with compliance officers and regulatory managers overseeing adherence to healthcare laws and standards.
   • Present solutions that simplify compliance reporting, risk assessments, or quality assurance processes.

4. Recruitment and Talent Acquisition

   • Engage HR professionals and department heads seeking skilled healthcare professionals, from clinical staff to administrative personnel.
   • Offer staffing services, recruitment platforms, or workforce optimization solutions to support hiring goals.

Why Choose Success.ai?

1. Best Price Guarantee

   • Access premium-quality data at competitive prices, ensuring strong ROI for your marketing, sales, and operational initiatives in the healthcare sector.

2. Seamless Integration

   • Incorporate verified healthcare data into CRM systems, marketing automation platforms, or analytics dashboards via APIs or downloadable form...

The European healthcare big data analytics market is experiencing robust growth, driven by the increasing volume of healthcare data generated through electronic health records (EHRs), wearable devices, and other digital health technologies. This surge in data necessitates advanced analytics capabilities to improve patient care, optimize operational efficiency, and accelerate drug discovery. The market's Compound Annual Growth Rate (CAGR) of 19% from 2019 to 2024 signifies significant market expansion, projected to continue into the forecast period (2025-2033). Key drivers include the rising prevalence of chronic diseases demanding personalized medicine, stringent regulatory requirements for data security and interoperability, and government initiatives promoting digital health transformation across Europe. The market is segmented by technology type (predictive, prescriptive, and descriptive analytics), application (clinical, financial, and operational), product (hardware, software, and services), delivery mode (on-premise and cloud-based), and end-user (healthcare providers, pharmaceutical and biotechnology companies, and academic organizations). The strong presence of major players like IBM, Oracle, Cerner, and McKesson indicates a competitive yet rapidly evolving landscape. Growth is particularly strong in countries like the UK, Germany, and France, reflecting higher healthcare expenditure and technological adoption rates. However, challenges remain, including data privacy concerns, the need for robust cybersecurity infrastructure, and the integration of legacy systems with new data analytics platforms. Overcoming these hurdles is key to unlocking the full potential of big data analytics in improving healthcare outcomes across Europe. The projected market value for 2025 serves as a strong baseline for forecasting future growth. Considering the 19% CAGR and the inherent growth potential in the healthcare sector, a sustained, albeit slightly moderated, growth rate is anticipated for the coming years. The market is expected to see continued investment in cloud-based solutions, driven by their scalability, cost-effectiveness, and accessibility. The focus on predictive analytics will likely increase, aiming to anticipate patient needs and optimize resource allocation. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) within big data analytics platforms is poised to accelerate innovation and further propel market growth. The ongoing emphasis on interoperability across healthcare systems will stimulate demand for integrated data analytics solutions, leading to greater efficiency and improved data-driven decision making. This continued growth will solidify Europe's position as a key player in the global healthcare big data analytics market. Recent developments include: May 2022 : The European Health Data Space was introduced by the European Commission (EHDS). The EHDS should assist the EU in significantly improving how healthcare is supplied to people throughout Europe. People should be able to manage and use their health information in their nation or another Member State. It should promote a single market for services and goods related to digital health. Additionally, it should guarantee complete adherence to the stringent data protection requirements set by the EU and provide a consistent, reliable, and effective framework for using health data for research, innovation, policy-making, and regulatory activities., November 2022 : The largest health services provider in Israel, Clalit, and IQVIA, a leading global provider of advanced analytics, technological solutions, and clinical research services to the life sciences sector, have announced a long-term partnership. The partnership assures IQVIA it can meet the pharmaceutical industry's interest in Israel as a top location for research and innovation by combining Clalit's aim to improve policy and healthcare with IQVIA's Connected Intelligence.. Key drivers for this market are: Reduced Cost of Care and Prediction of Possible Emergency Services, Increasing Evidence-based Activities and Shift from Volume- to Value-based Commissioning. Potential restraints include: Reduced Cost of Care and Prediction of Possible Emergency Services, Increasing Evidence-based Activities and Shift from Volume- to Value-based Commissioning. Notable trends are: Clinical Data Analytics to Witness Significant Growth Over the Forecast Period.

The objective of this study was to develop an agent based modeling (ABM) framework to simulate the behavior of patients who leave a public hospital emergency department (ED) without being seen (LWBS). In doing so, the study complements computer modeling and cellular automata (CA) techniques to simulate the behavior of patients in an ED. After verifying and validating the model by comparing it with data from a real case study, the significance of four preventive policies including increasing number of triage nurses, fast-track treatment, increasing the waiting room capacity and reducing treatment time were investigated by utilizing ordinary least squares regression. After applying the preventing policies in ED, an average of 42.14% reduction in the number of patients who leave without being seen and 6.05% reduction in the average length of stay (LOS) of patients was reported. This study is the first to apply CA in an ED simulation. Comparing the average LOS before and after applying CA with actual times from emergency department information system showed an 11% improvement. The simulation results indicated that the most effective approach to reduce the rate of LWBS is applying fast-track treatment. The ABM approach represents a flexible tool that can be constructed to reflect any given environment. It is also a support system for decision-makers to assess the relative impact of control strategies.